119 related articles for article (PubMed ID: 3940740)
1. Urinary excretion rates of 15 free steroids: potential utility in differential diagnosis of Cushing's syndrome.
Schöneshöfer M; Weber B; Oelkers W; Nahoul K; Mantero F
Clin Chem; 1986 Jan; 32(1 Pt 1):93-6. PubMed ID: 3940740
[TBL] [Abstract][Full Text] [Related]
2. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome.
Lin CL; Wu TJ; Machacek DA; Jiang NS; Kao PC
J Clin Endocrinol Metab; 1997 Jan; 82(1):151-5. PubMed ID: 8989250
[TBL] [Abstract][Full Text] [Related]
3. [Plasma steroid hormones in Cushing's syndrome: their relation to cause and clinical manifestations (author's transl)].
Horio S; Funahashi H; Mizuno S
Nihon Naibunpi Gakkai Zasshi; 1981 May; 57(5):807-25. PubMed ID: 7286345
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
Cunningham SK; McKenna TJ
Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
[TBL] [Abstract][Full Text] [Related]
5. Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
Cassar J; Loizou S; Kelly WF; Mashiter K; Joplin GF
Metabolism; 1980 Feb; 29(2):115-9. PubMed ID: 7354720
[TBL] [Abstract][Full Text] [Related]
6. Serum profiles of steroid hormones in patients with Cushing's syndrome determined by a new HPLC/RIA method.
Ueshiba H; Segawa M; Hayashi T; Miyachi Y; Irie M
Clin Chem; 1991 Aug; 37(8):1329-33. PubMed ID: 1868592
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
[TBL] [Abstract][Full Text] [Related]
8. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
Levine AC; Mitty HA; Gabrilove JL
J Urol; 1988 Jul; 140(1):11-5. PubMed ID: 2967899
[TBL] [Abstract][Full Text] [Related]
9. Gas Chromatography-Mass Spectrometry Analysis of Urinary Steroid Metabolomics for Detection of Early Signs of Adrenal Neoplasm Malignancy in Patients with Cushing's Syndrome.
Velikanova LI; Shafigullina ZR; Vorokhobina NV; Malevanaya EV
Bull Exp Biol Med; 2019 Sep; 167(5):676-680. PubMed ID: 31630306
[TBL] [Abstract][Full Text] [Related]
10. Urinary steroid profile in adrenocortical tumors.
Kikuchi E; Yanaihara H; Nakashima J; Homma K; Ohigashi T; Asakura H; Tachibana M; Shibata H; Saruta T; Murai M
Biomed Pharmacother; 2000 Jun; 54 Suppl 1():194s-197s. PubMed ID: 10915023
[TBL] [Abstract][Full Text] [Related]
11. Measurement of urinary steroid profile in patients with adrenal tumor as a screening method for carcinoma.
Minowada S; Kinoshita K; Hara M; Isurugi K; Uchikawa T; Niijima T
Endocrinol Jpn; 1985 Feb; 32(1):29-37. PubMed ID: 4017973
[TBL] [Abstract][Full Text] [Related]
12. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B
Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879
[TBL] [Abstract][Full Text] [Related]
13. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[TBL] [Abstract][Full Text] [Related]
14. [The effects of o,p'-DDD on human adrenal steroid synthesis].
Ojima M; Saito M; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274
[TBL] [Abstract][Full Text] [Related]
15. [Special diagnosis in Cushing's syndrome].
Tenschert W; Vetter H; Siebenschein R; Holland-Cunz B; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1981 Jan; 111(3):70-3. PubMed ID: 6944789
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma.
Takeda Y; Lewicka S; Koch S; Bige K; Vecsei P; Abdelhamid S; Cojocaru M; Harnik M
J Steroid Biochem Mol Biol; 1990 Nov; 37(4):599-604. PubMed ID: 2278845
[TBL] [Abstract][Full Text] [Related]
17. Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotyping.
Braun LT; Osswald A; Zopp S; Rubinstein G; Vogel F; Riester A; Honegger J; Eisenhofer G; Constantinescu G; Deutschbein T; Quinkler M; Elbelt U; Künzel H; Nowotny HF; Reisch N; Hartmann MF; Beuschlein F; Pons-Kühnemann J; Reincke M; Wudy SA
EBioMedicine; 2024 Jan; 99():104907. PubMed ID: 38128413
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
[TBL] [Abstract][Full Text] [Related]
19. Excretion patterns of urinary 17-KS and 17-OHCS in patients with Cushing's syndrome.
Mizutani S; Sonoda T; Seki T; Matsumoto K
Urol Int; 1974; 29(5):341-50. PubMed ID: 4276760
[No Abstract] [Full Text] [Related]
20. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
